FR3015526B1 - NPY1R BIOMARKER OF LENTIGO ACTINIQUE - Google Patents

NPY1R BIOMARKER OF LENTIGO ACTINIQUE

Info

Publication number
FR3015526B1
FR3015526B1 FR1363211A FR1363211A FR3015526B1 FR 3015526 B1 FR3015526 B1 FR 3015526B1 FR 1363211 A FR1363211 A FR 1363211A FR 1363211 A FR1363211 A FR 1363211A FR 3015526 B1 FR3015526 B1 FR 3015526B1
Authority
FR
France
Prior art keywords
actinique
npy1r
lentigo
biomarker
npy1r biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1363211A
Other languages
French (fr)
Other versions
FR3015526A1 (en
Inventor
Lacharriere Olivier De
Stephanie Nouveau
Francoise Bernerd
Christine Duval
Emilie Warrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1363211A priority Critical patent/FR3015526B1/en
Priority to PCT/EP2014/078592 priority patent/WO2015091872A1/en
Publication of FR3015526A1 publication Critical patent/FR3015526A1/en
Application granted granted Critical
Publication of FR3015526B1 publication Critical patent/FR3015526B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
FR1363211A 2013-12-20 2013-12-20 NPY1R BIOMARKER OF LENTIGO ACTINIQUE Expired - Fee Related FR3015526B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1363211A FR3015526B1 (en) 2013-12-20 2013-12-20 NPY1R BIOMARKER OF LENTIGO ACTINIQUE
PCT/EP2014/078592 WO2015091872A1 (en) 2013-12-20 2014-12-18 Npy1r biomarker for actinic lentigo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1363211A FR3015526B1 (en) 2013-12-20 2013-12-20 NPY1R BIOMARKER OF LENTIGO ACTINIQUE

Publications (2)

Publication Number Publication Date
FR3015526A1 FR3015526A1 (en) 2015-06-26
FR3015526B1 true FR3015526B1 (en) 2017-02-17

Family

ID=50976698

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1363211A Expired - Fee Related FR3015526B1 (en) 2013-12-20 2013-12-20 NPY1R BIOMARKER OF LENTIGO ACTINIQUE

Country Status (2)

Country Link
FR (1) FR3015526B1 (en)
WO (1) WO2015091872A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8163764B2 (en) * 2002-04-26 2012-04-24 Asan Laboratories Company (Cayman) Limited Skincare methods
JP2004026786A (en) * 2002-05-10 2004-01-29 Takeda Chem Ind Ltd Vitamin preparation
JP2006513702A (en) * 2002-09-09 2006-04-27 ヌラ インコーポレーティッド G protein-coupled receptor and use thereof
US20060058387A1 (en) * 2004-09-15 2006-03-16 Albert Aebi Composition and method for treating skin conditions
FR2895253B1 (en) * 2005-12-22 2008-05-30 Oreal USE OF AN AGONIST OF NEUROPEPTIDE Y FOR NATURALLY REPULTING AND / OR COLORING LIP
BRPI0913578A2 (en) * 2008-05-14 2017-06-06 Dermtech Int diagnosis of melanoma and solar lentigo by nucleic acid analysis
CN105362151A (en) * 2010-03-31 2016-03-02 株式会社爱茉莉太平洋 Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
EP2699221B1 (en) * 2011-04-22 2017-02-08 L'Oréal Molecular signature for skin pigment spots, which is combined with the extracellular matrix

Also Published As

Publication number Publication date
WO2015091872A1 (en) 2015-06-25
FR3015526A1 (en) 2015-06-26

Similar Documents

Publication Publication Date Title
NO2022011I1 (en) Tigolaner / Emodepsid / Praziquantel
DK3011059T3 (en) IDENTIFICATION biomarker
DK2875743T3 (en) Kittel
AR095266A1 (en) TETRACICLIC BROMODOMINES INHIBITORS
DK3527563T3 (en) DNA-PK INHIBITORS
DK3640241T3 (en) BROMO DOMAIN INHIBITORS
DK2863306T3 (en) Predictive autoscaling program
DK3043777T3 (en) SUBLINGUAL BUPRENORPHINSPRAY
DK3063144T3 (en) ANTIPARASITARY AND PESTICID-ISOXAZOLINE COMPOUNDS
DE112014004801A5 (en) phosphors
DK2991565T3 (en) EXPANDABLE BALLON
DK2970235T3 (en) NEW INHIBITORS
DK2984282T3 (en) EXPANDABLE WELL PIPE
BR112015021083A2 (en) method
DK3030484T3 (en) Dynamic positioning vessel
BR112015029076A2 (en) method
DK3068314T3 (en) tourniquet
DK2821771T3 (en) Test Procedure
DK2946359T3 (en) PROCEDURE FOR EVALUATION OF CELL AGE
BR112015020275A2 (en) floating structure
FR3010712B1 (en) CAPSTAN
FR3015526B1 (en) NPY1R BIOMARKER OF LENTIGO ACTINIQUE
ES1083705Y (en) MANUAL DEVELOPER
FR3015525B1 (en) BIOMARKER RNASE 7 OF LENTIGO ACTINIQUE
FR3028953B1 (en) SAMPLER OF GRAINS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20210805